Renoprotection in Type 2 diabetes: blockade of the renin-angiotensin system with angiotensin II receptor blockers.
Swift, P A
Renoprotection in Type 2 diabetes: blockade of the renin-angiotensin system with angiotensin II receptor blockers. [electronic resource] - Journal of the renin-angiotensin-aldosterone system : JRAAS Sep 2001 - 170-3 p. digital
Publication Type: Editorial; Review
1470-3203
10.3317/jraas.2001.023 doi
Angiotensin Receptor Antagonists
Antihypertensive Agents--therapeutic use
Biphenyl Compounds--therapeutic use
Diabetes Mellitus, Type 2--drug therapy
Humans
Irbesartan
Kidney--drug effects
Losartan--therapeutic use
Randomized Controlled Trials as Topic
Renin-Angiotensin System--drug effects
Tetrazoles--therapeutic use
Renoprotection in Type 2 diabetes: blockade of the renin-angiotensin system with angiotensin II receptor blockers. [electronic resource] - Journal of the renin-angiotensin-aldosterone system : JRAAS Sep 2001 - 170-3 p. digital
Publication Type: Editorial; Review
1470-3203
10.3317/jraas.2001.023 doi
Angiotensin Receptor Antagonists
Antihypertensive Agents--therapeutic use
Biphenyl Compounds--therapeutic use
Diabetes Mellitus, Type 2--drug therapy
Humans
Irbesartan
Kidney--drug effects
Losartan--therapeutic use
Randomized Controlled Trials as Topic
Renin-Angiotensin System--drug effects
Tetrazoles--therapeutic use